This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.
The assessments include:
Sales
Product portfolios
Distribution tactics
Technological know-how
New products in R&D
Collaborative arrangements
Business strategies.
Contains 80 pages